KWILP
WST icon

Kiwi Wealth Investments Limited Partnership’s West Pharmaceutical WST Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,694
Closed -$385K – 267
2020
Q2 		$385K Sell
1,694
-17,902
-91% -$3.52M 0.03% 199
2020
Q1 		$2.98M Buy
+19,596
New +$3.02M 0.3% 92

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's WST Position: Q3 2020 in Review

Kiwi Wealth Investments Limited Partnership sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 1,694 shares — an estimated $385K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in WST in Q1 2020 and held it in 2 quarters. The position peaked at $2.98M in Q1 2020. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • Kiwi Wealth Investments Limited Partnership reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 1,694 West Pharmaceutical shares in Q3 2020, an estimated $385K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in West Pharmaceutical in Q1 2020 and held it in 2 quarters.
  • Kiwi Wealth Investments Limited Partnership's West Pharmaceutical position peaked at $2.98M in Q1 2020.
  • 574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2020, filed 16 Nov 2020.